The D.C. Cannabis Board has approved a settlement resolving enforcement action against West2East, LLC, operating as West2East/Blossomz, following its February 2026 summary closure by regulators at its Fenwick Street NE cultivation site. Under the agreement, the company must pay a $10,000 fine, remain under continued closure, and submit all required paperwork within 90 days to complete the sale of its cultivation license to an unrelated third party or face permanent revocation. The settlement stems from ABCA’s earlier enforcement action, which marked one of the District’s first shutdowns of a licensed medical cannabis cultivator, and it restricts West2East from conducting any cannabis operations while allowing only limited, regulator-supervised access to secure inventory and prepare for a potential transfer.
- The next ABC Board meeting is May 6, 2026: watch, agenda.
- Catch up on the April 29 disposition.
- A new cannabis consumption lounge called Higher Ground has opened in Washington, D.C., positioning itself as the East Coast’s largest cannabis lounge and a “third space” combining retail sales, on-site consumption, education, and events.
Virginia cannabis retail launch stalls as lawmakers reject Spanberger’s proposed changes
Virginia’s long-delayed adult-use cannabis retail market is in limbo after lawmakers rejected Gov. Abigail Spanberger’s proposed changes to the legalization bill, sending it back to her with limited options. The governor had sought to delay retail sales, revise market structure, and adjust penalties, but legislators opted to preserve the original framework targeting a 2027 launch. Spanberger must now either sign the bill as written or veto it, a decision that will determine whether Virginia finally moves forward with a regulated cannabis market or remains in a legal gray area.
Virginia Cannabis Authority sets aggressive timeline for adult-use market as 2027 launch takes shape
Virginia’s Cannabis Control Authority outlined an accelerated timeline to launch an adult-use cannabis market, with licensing potentially beginning in September 2026 and retail sales targeted for Jan. 1, 2027. While Abigail Spanberger proposed amendments to delay the launch to July 2027, lawmakers rejected those changes and returned the bill unchanged, leaving the governor to decide whether to sign, veto, or allow it to become law. The agency would oversee regulation of the full supply chain, including cultivation, processing, testing, transportation, and retail, and has already begun preparing its 2027 budget based on the potential launch. Overall, the meeting highlighted a fast-moving regulatory push that is now awaiting final executive action rather than further legislative revision.
Maryland expands worker protections, allowing off-duty medical cannabis use for fire and rescue personnel
Maryland Gov. Wes Moore signed legislation allowing fire and rescue public safety employees to use medical cannabis while off duty without facing workplace discrimination. The law prohibits employers from disciplining, firing, or otherwise penalizing registered medical cannabis patients solely for lawful use, including positive drug tests for cannabis metabolites. However, the policy preserves strict prohibitions on on-duty impairment, maintaining employer authority to enforce safety standards while balancing employee protections.
ICYMI: Federal Schedule III shift triggers D.C., Maryland cannabis uncertainty
East Coast Roundup
West Virginia’s Supreme Court will decide whether the smell of cannabis alone provides sufficient probable cause for law enforcement to conduct a home search, a ruling that could reshape search-and-seizure standards in legal cannabis states.
New York researchers are preparing expanded clinical studies into cannabis’ medical efficacy following federal reclassification, aiming to clarify treatment potential across multiple conditions.
New York regulators are flagging a rise in illicit cannabis sales in Rochester, highlighting ongoing enforcement challenges despite the state’s legal market rollout.
Culture & More
New research from China shows cannabis was a foundational crop in ancient societies, widely used for fiber, food, and medicine, underscoring its historical economic importance.
The DEA has launched a new online registration portal for medical cannabis firms, streamlining compliance requirements as federal policy shifts.
Legalization sidelined traditional glass bong makers, as corporate cannabis brands and regulated retail reshape consumer purchasing trends.
Around the Country
Authorities in Oklahoma have charged 51 individuals in a large-scale illegal cannabis trafficking operation, signaling continued crackdown efforts in oversupplied markets.
A new class action lawsuit alleges cartel-linked manipulation of Missouri’s cannabis market, raising concerns about regulatory oversight and market integrity.
Despite prohibition, Indiana residents are driving over $1 billion in cannabis purchases, largely through out-of-state legal markets, illustrating significant cross-border economic leakage.
From the swamp
The U.S. House passed a federal farm bill without addressing hemp-derived cannabinoid regulations, leaving a major policy gap for intoxicating hemp products.
Cannabis industry stakeholders are navigating uncertainty around Donald Trump’s evolving stance on legalization and federal reform ahead of the election cycle.
The FDA is accelerating review timelines for three psychedelic drug candidates, signaling growing federal openness to alternative therapeutics.Confusion persists around the Trump administration’s cannabis rescheduling approach, with unclear regulatory direction creating uncertainty for state-legal markets and businesses.
